Literature DB >> 31446565

Production of Lysostaphin by Nonproprietary Method Utilizing a Promoter from Toxin-Antitoxin System.

Anna Mądry1, Agnieszka Jendroszek1, Grzegorz Dubin2, Benedykt Wladyka3.   

Abstract

Lysostaphin is a staphylolytic protein of growing interest from biotechnological and pharmaceutical industry due to its potential use in preventing and combating staphylococcal infections. Here, we describe an optimized method for production of lysostaphin in an inductionless system utilizing constitutive promoter from staphylococcal toxin-antitoxin system PemIK-Sa1. We investigated the influence of ribosome-binding site sequence, Escherichia coli producer strain and growth media on yield and kinetics of recombinant protein production. Lysostaphin was purified in its native active form using one-step cation-exchange chromatography. The system provides a method for cost-efficient and scalable protein production, and can be applied to produce other biotechnologically significant proteins.

Entities:  

Keywords:  Ion exchange chromatography; Lysostaphin; Protein expression; Recombinant protein; Staphylococcus; Toxin–antitoxin system

Mesh:

Substances:

Year:  2019        PMID: 31446565     DOI: 10.1007/s12033-019-00203-4

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  66 in total

1.  Cloning, expression, and purification of the Staphylococcus simulans lysostaphin using the intein-chitin-binding domain (CBD) system.

Authors:  P Szweda; R Pladzyk; R Kotlowski; J Kur
Journal:  Protein Expr Purif       Date:  2001-08       Impact factor: 1.650

2.  Whole proteome pI values correlate with subcellular localizations of proteins for organisms within the three domains of life.

Authors:  R Schwartz; C S Ting; J King
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

3.  Cloning and expression of the lysostaphin gene in Bacillus subtilis and Lactobacillus casei.

Authors:  W Gaier; R F Vogel; W P Hammes
Journal:  Lett Appl Microbiol       Date:  1992-03       Impact factor: 2.858

4.  LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

5.  PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Biochim Biophys Acta       Date:  1965-02-15

6.  LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

Authors:  H P BROWDER; W A ZYGMUNT; J R YOUNG; P A TAVORMINA
Journal:  Biochem Biophys Res Commun       Date:  1965-04-23       Impact factor: 3.575

7.  Culture conditions differentially affect the translation of individual Escherichia coli mRNAs.

Authors:  N Jacques; J Guillerez; M Dreyfus
Journal:  J Mol Biol       Date:  1992-08-05       Impact factor: 5.469

8.  Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.

Authors:  J J Dajcs; E B Hume; J M Moreau; A R Caballero; B M Cannon; R J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

9.  Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.

Authors:  Julie A Wu; Caroline Kusuma; James J Mond; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

10.  High-level expression and purification of mature HIV-1 protease in Escherichia coli under control of the araBAD promoter.

Authors:  A Taylor; D P Brown; S Kadam; M Maus; W E Kohlbrenner; D Weigl; M C Turon; L Katz
Journal:  Appl Microbiol Biotechnol       Date:  1992-05       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.